Low levels of the endogenous endocannabinoid arachidonoylethanolamide are predictive of symptomatic in-stent restenosis after coronary implantation of drug-eluting stents / Vignali, L; Talanas, Giuseppe; Menozzi, Alberto; Cattabiani Maria, Alberta; Solinas, Emilia; Emanuele, Enzo; Ardissino, Diego. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 51:10(2008), pp. B93-B93.

Low levels of the endogenous endocannabinoid arachidonoylethanolamide are predictive of symptomatic in-stent restenosis after coronary implantation of drug-eluting stents

Vignali L;
2008-01-01

2008
Low levels of the endogenous endocannabinoid arachidonoylethanolamide are predictive of symptomatic in-stent restenosis after coronary implantation of drug-eluting stents / Vignali, L; Talanas, Giuseppe; Menozzi, Alberto; Cattabiani Maria, Alberta; Solinas, Emilia; Emanuele, Enzo; Ardissino, Diego. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 51:10(2008), pp. B93-B93.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/3024827
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact